BRCA2 and breast cancer: On the other hand, the CIMBA study reported a negative ERα status both in BRCA1 and BRCA2-associated BC as associated with a higher histological grade than positive ERα status tumors (p = 1.2 × 10−13 for BRCA1 and p = 0.001 for BRCA2) [46].